Abstract
Cross-sectional data often fail to show beneficial effects of antihypertensive therapy in patients with hypertension. We, therefore, examined the influence of hypertension control on left ventricular (LV) structure in diabetic persons separated into those having and not having any known cardiovascular disease (CVD) symptoms. The study population consisted of 394 subjects with type II diabetes. According to the presence of CVD, subjects were classified as symptomatic (N=181) or asymptomatic (N=213). In addition, three groups were differentiated: controlled hypertensives (CHs), that is, known hypertension with normal blood pressure (BP), uncontrolled hypertensives (UHs), that is, elevated BP regardless of antihypertensive medication, and normotensives (Ns). Symptomatic subjects showed a significantly higher prevalence of LV hypertrophy (LVH) (34.5 vs 23.4%, P<0.02). In contrast to symptomatic subjects where hypertension control status had no further significant impact on LV geometry, a considerable impact on preservation of normal LV geometry was observed in asymptomatic persons (LVH of 30, 15 and 18% in UH, CH and N, respectively, P<0.001). Control of hypertension in early diabetes seems especially to prevent the development of concentric hypertrophy (24 vs 11% in UH vs CH, P<0.04). In conclusion, in subjects with diabetes and CVD, the prevalence of LV structural abnormalities is very high. Although in this population-based study setting, in the latter group BP control does not seem to positively influence LV mass and function, hypertension control in still asymptomatic diabetic persons is beneficial and has a considerable impact on preservation of normal LV geometry.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Butler RA, MacDonald TM, Struthers AD, Morris AD . The clinical implications of diabetic heart disease. Eur Heart J 1998; 19: 1617–1627.
Garcia MJ, McNamara PM, Gordon T, Kannel WB . Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes 1974; 23: 105–111.
Grossman E, Shemesh J, Shamiss A, Thaler M, Carroll J, Rosenthal T . Left ventricular mass in diabetes–-hypertension. Arch Intern Med 1992; 152: 1001–1004.
Francis GS . Diabetic cardiomyopathy: fact or fiction? Heart 2001; 85: 247–248.
Palmieri V, Bella JN, Arnett DK, Liu JE, Oberman A, Schuck MY et al. Impact of type II diabetes on left ventricular geometry, and systolic function in hypertensive subjects. The Hypertension Genetic Epidemiology Network (HyperGEN) Study. Circulation 2001; 103: 102–107.
Nicolino A, Longobardi G, Furgi G, Rossi M, Zoccolillo N, Ferrara N et al. Left ventricular diastolic filling in diabetes mellitus with and without hypertension. Am J Hypertens 1995; 8: 382–389.
Bella JN, Devereux RB, Roman MJ, Palmieri V, Liu JE, Paranicas M et al. Separate and joint effects of systemic hypertension and diabetes mellitus on left ventricular structure and function in American Indians (the Strong Heart Study). Am J Cardiol 2001; 87: 1260–1265.
Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH . Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345–352.
Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Battistelli M, Bartoccini C et al. Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass. Am Coll Cardiol 1995; 25: 871–878.
Krumholz HM, Larson M, Levy D . Prognosis of left ventricular geometric patterns in the Framingham Heart Study. J Am Coll Cardiol 1995; 25: 879–884.
Eguchi K, Kario K, Hoshide S, Ishikawa J, Morinari M, Shimada K . Type 2 diabetes is associated with left ventricular concentric remodeling in hypertensive patients. Am J Hypertens 2005; 18: 23–29.
UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703–713.
Mogensen CE . Combined high blood pressure and glucose in type 2 diabetes. Double jeopardy. BMJ 1998; 317: 693–694.
UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ 1998; 317: 713–720.
Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Menard J, et al. for the HOT Study Group. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351: 1755–1762.
Estacio RO, Jeffers BW, Hiatt WR, Biggerstaff SL, Gifford N, Schrier RW . The effect of nisoldipine as compared to enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med 1998; 338: 645–652.
Gudmundsson LS, Johannsson M, Thorgeirsson G, Sigfusson N, Sigvaldason H, Witteman JC . Risk profiles and prognosis of treated and untreated hypertensive men and women in a population-based longitudinal study: the Reykjavik Study. J Hum Hypertens 2004; 18: 615–622.
Koro CE, Bowlin SJ, Weiss S . Antidiabetic therapy and the risk of heart failure in type 2 diabetic patients. An independent effect or confounding by indication. Pharmacoepidemiol Drug Saf 2005; 14: 697–703.
McMahon AD . Approaches to combat with confounding by indication in observational studies of intended drug effects. Pharmacoepidemiol Drug Safety 2003; 12: 551–558.
Meisinger C, Thorand B, Schneider A, Stieber J, Döring A, Löwel H . Sex differences in risk factors for incident type 2 diabetes. The MONICA Augsburg Cohort Study. Arch Intern Med 2002; 162: 82–89.
Hense HW, Gneiting B, Muscholl M, Broeckel U, Kuch B, Döring A et al. The associations of body size and body composition with left ventricular mass: Impacts for indexation in adults. J Am Coll Cardiol 1998; 32: 451–457.
Kuch B, Hense HW, Gneiting B, Döring, A, Muscholl M et al. Body composition and prevalence of left ventricular hypertrophy. Circulation 2000; 102: 405–410.
Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450–458.
Schunkert H, Hense HW, Muscholl M, Luchner A, Kurzinger S, Danser AH et al. Associations between circulating components of the renin–angiotensin–aldosterone system and left ventricular mass. Heart 1997; 77: 24–31.
Lee M, Gardin JM, Lynch JC, Smith VE, Tracy RP, Savage PJ et al. Diabetes mellitus and echocardiographic left ventricular function in free-living elderly men and women: the Cardiovascular Health Study. Am Heart J 1997; 133: 36–43.
Kuch B, Schunkert H, Muscholl M, Doring A, von Scheidt W, Hense HW . Distribution, determinants and reference values of left ventricular parameters in the general population – results of the MONICA/KORA Echocardiography Studies. Gesundheitswesen 2005; 67 (Suppl 1): 68–73.
Ganau A, Devereux RB, Roman RJ, de Simone G, Pickering TG, Saba PS et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992; 19: 1550–1558.
Kuch B, Muscholl M, Döring A, Riegger G, Schunkert H, Hense HW . Gender specific differences in left ventricular adaptation to obesity and hypertension. J Hum Hypertens 1998; 12: 685–691.
Dumesnil JG, Gaudreault G, Honos GN, Kingma JG . Use of Valsalva maneuver to unmask left ventricular diastolic function abnormalities by Doppler echocardiography in patients with coronary artery disease or systemic hypertension. Am J Cardiol 1991; 68: 515–519.
World Health Organization. Definition, diagnosis and classification of diabetes mellitus and Its complications. Report of a WHO Consultation Part 1. Diagnosis and classification of diabetes mellitus. WHO: Geneva, 1999 pp 1–59.
Heyden S, Bartel AG, Tabesh E, Cassel JC, Tyroler HA et al. Angina pectoris and the Rose questionnaire. Arch Intern Med 1971; 128: 961–964.
Arauz-Pacheco C, Parrott MA, Raskin P . The treatment of hypertension in adult patients with diabetes. Diab Care 2002; 25: 134–147.
Struthers AD, Morris AD . Screening for and treating left-ventricular abnormalities in diabetes mellitus: a new way of reducing cardiac deaths. Lancet 2002; 359: 1430–1432.
Holmang A, Yoshida N, Jennische E, Waldenstrom A, Bjorntorp P . The effects of hyperinsulinaemia on myocardial mass, blood pressure regulation and central haemodynamics in rats. Eur J Clin Invest 1996; 26: 973–978.
Marcus R, Krause L, Weder AB, Dominguez-Meja A, Schork NJ, Julius S . Sex-specific determinants of increased left ventricular mass in the Tecumseh Blood Pressure Study. Circulation 1994; 90: 928–936.
Grant RW, Cagliero E, Murphy-Sheehy P, Singer DE, Nathan DM, Meigs JB . Comparison of hyperglycemia, hypertension, and hypercholesterolemia management in patients with Type 2 diabetes. Am J Med 2002; 112: 603–609.
Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004; 43: 10–17.
Mulè G, Nardi E, Cottone S, Andronico G, Federico MR, Piazza G et al. Relationships between ambulatory white coat effect and left ventricular mass in arterial hypertension. Am J Hypertens 2003; 16: 498–501.
Mancia G, Carugo S, Grassi G, Lanzarotti A, Schiavina R, Cesana G et al. Prevalence of left ventricular hypertrophy in hypertensive patients without and with blood pressure control: data from the PAMELA population. Pressioni Arteriose Monitorate E Loro Associazioni. Hypertension 2002; 39: 44–49.
Kosmala W, Kucharski W, Przewlocka-Kosmala M, Mazurek W . Comparison of left ventricular function by tissue Doppler imaging in patients with diabetes mellitus without systemic hypertension versus diabetes mellitus with systemic hypertension. Am J Cardiol 2004; 94: 395–399.
Fang ZY, Najos-Valencia O, Leano R, Marwick TH . Patients with early diabetic heart disease demonstrate a normal response to dobutamine. J Am Coll Cardiol 2003; 42: 446–453.
Acknowledgements
The KORA research platform was initiated and financed by the GSF – National Research Center for Environment and Health, which is funded by the German Federal Ministry of Education, Science, Research and Technology and by the State of Bavaria. The Augsburg Diabetes Family Study was mainly financed by the GSF and additionally supported by funds from the German Research Foundation (DFG-FKZ: WI 621/8-1). We thank all members of the GSF Institute of Epidemiology and the field staff in Augsburg who were involved in the planning and conduct of the study. Finally, we express our appreciation to all study participants.
This work was supported by the German Research Foundation (DFG-FKZ: WI 621/8-1).
Author information
Authors and Affiliations
Corresponding author
Additional information
Conflicts of interest: None
Rights and permissions
About this article
Cite this article
Kuch, B., von Scheidt, W., Peter, W. et al. Influence of antihypertensive therapy and blood pressure control on left ventricular geometry and function in subjects with type II diabetes: The Augsburg Diabetes Family Study. J Hum Hypertens 20, 757–764 (2006). https://doi.org/10.1038/sj.jhh.1002062
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1002062
Keywords
This article is cited by
-
The ADVANCE trial: further PROGRESS with HOPE
Journal of Human Hypertension (2007)